Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Description

This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.

Conditions

Urinary Retention

Study Overview

Study Details

Study overview

This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Condition
Urinary Retention
Intervention / Treatment

-

Contacts and Locations

Brick

Ocean University Medical Center, Brick, New Jersey, United States, 08724

Manahawkin

South Ocean University Medical Center, Manahawkin, New Jersey, United States, 08050

Neptune

Jersey Shore University Medical Center, Neptune, New Jersey, United States, 07753

Red Bank

Riverview Medical Center, Red Bank, New Jersey, United States, 07701

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Males
  • * ≥55 years old
  • * Planned thoracic oncological surgical procedure of a video assisted oncological surgical procedure for suspected or confirmed cancer.
  • * Surgery scheduled more than 7 days from the time of consent
  • * Using Tamsulosin already
  • * Known allergy to Tamsulosin or sulfa drugs
  • * Current use of Boceprevir
  • * Resting systolic blood pressure \<100
  • * Orthostatic hypotension of \>20mm Hg systolic and/or 10mm Hg diastolic pressure from sitting to standing (after 2 minutes of standing) as measured at the time of consent
  • * Known history of hypotension
  • * Known diagnosis of congestive heart failure (CHF) and valvular heart disease
  • * History of prior prostate surgery (prostatectomy, trans-urethral resection)

Ages Eligible for Study

55 Years to

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Hackensack Meridian Health,

Thomas Bauer, MD, PRINCIPAL_INVESTIGATOR, Hackensack Meridian Health

Study Record Dates

2026-12